Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide

Cited 115 time in webofscience Cited 118 time in scopus
  • Hit : 304
  • Download : 33
DC FieldValueLanguage
dc.contributor.authorLee, Soo Hyeonko
dc.contributor.authorKim, Sun Hwako
dc.contributor.authorPark, Tae Gwanko
dc.date.accessioned2009-11-10T08:28:06Z-
dc.date.available2009-11-10T08:28:06Z-
dc.date.created2012-02-06-
dc.date.created2012-02-06-
dc.date.issued2007-06-
dc.identifier.citationBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, v.357, no.2, pp.511 - 516-
dc.identifier.issn0006-291X-
dc.identifier.urihttp://hdl.handle.net/10203/12374-
dc.description.abstractTo develop a small interfering RNA (siRNA) delivery system with low cytotoxicity and high transfection efficiency, siRNA was conjugated to poly(ethylene glycol) via a disulfide linkage (siRNA-PEG) to prepare polyelectrolyte complex micelles (PECMs) by condensing with a cationic fusogenic peptide (KALA). The siRNA-PEG conjugate exhibited enhanced resistance to degradation from nucleases. Anionic siRNA-PEG conjugate and cationic KALA, when mixed in an aqueous phase, spontaneously formed nano-sized PECMs (< 200 nm) that have an inner core of charge neutralized siRNA/KALA complex surrounded by a PEG corona. Vascular endothelial growth factor (VEGF) siRNA was used to demonstrate VEGF sequence-specific gene inhibition in prostate carcinoma cells (PC-3 cells). The extent of gene silencing was gradually increased with increasing nitrogen to phosphate (N/P) ratio and the concentration of siRNA-PEG/KALA PECMs. These results suggest that the formulation of siRNA-PEG/KALA PECMs could be widely applied for intracellular delivery of various therapeutic siRNAs. (c) 2007 Elsevier Inc. All rights reserved.-
dc.description.sponsorshipMinistry of Science and Technology (National Research Laboratory Project) and the National Cancer Center, South Korea.en
dc.languageEnglish-
dc.language.isoen_USen
dc.publisherACADEMIC PRESS INC ELSEVIER SCIENCE-
dc.subjectANTISENSE OLIGONUCLEOTIDE-
dc.subjectGLYCOL) CONJUGATE-
dc.subjectGENE DELIVERY-
dc.subjectIN-VIVO-
dc.subjectGLUTATHIONE-
dc.subjectOLIGODEOXYNUCLEOTIDE-
dc.subjectTHERAPEUTICS-
dc.subjectRNAS-
dc.titleIntracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide-
dc.typeArticle-
dc.identifier.wosid000246253700030-
dc.identifier.scopusid2-s2.0-34247153120-
dc.type.rimsART-
dc.citation.volume357-
dc.citation.issue2-
dc.citation.beginningpage511-
dc.citation.endingpage516-
dc.citation.publicationnameBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS-
dc.identifier.doi10.1016/j.bbrc.2007.03.185-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.contributor.localauthorPark, Tae Gwan-
dc.contributor.nonIdAuthorLee, Soo Hyeon-
dc.contributor.nonIdAuthorKim, Sun Hwa-
dc.type.journalArticleArticle-
dc.subject.keywordAuthorsiRNA delivery-
dc.subject.keywordAuthorPEG-
dc.subject.keywordAuthorfusogenic peptide-
dc.subject.keywordAuthorvascular endothelial growth factor-
dc.subject.keywordAuthorpolyelectrolyte complex micelles-
dc.subject.keywordPlusANTISENSE OLIGONUCLEOTIDE-
dc.subject.keywordPlusGLYCOL) CONJUGATE-
dc.subject.keywordPlusGENE DELIVERY-
dc.subject.keywordPlusIN-VIVO-
dc.subject.keywordPlusGLUTATHIONE-
dc.subject.keywordPlusOLIGODEOXYNUCLEOTIDE-
dc.subject.keywordPlusTHERAPEUTICS-
dc.subject.keywordPlusRNAS-
Appears in Collection
BS-Journal Papers(저널논문)
Files in This Item
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 115 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0